Innovative protein-based and
cellular therapeutics
Drug discovery
Novel therapeutics to
tackle incurable diseases
Innovative natural products
with specific health effects

For the latest updates subscribe to our newsletter!

List of successful applications

Organising Mechanistic Knowledge about Neurodegenerative Diseases

2014. February 04.

Innovative Medicines Initiative 's AETIONOMY

Aetionomy, a public-private consortium funded by the Innovative Medicines Initiative (IMI), announced January, 2014 the launch of a 10,4 million Euro project focussing on organising mechanistic knowledge about neurodegenerative diseases for the improvement of drug development and therapy. Academic institutes, biotechnology companies and the pharmaceutical industry have joined forces to develope of a generic AETIONOMY pipeline to capture and infer over mechanistic knowledge of pathophysiology, and applicate of this pipeline to derive clinically significant mechanistic taxonomies of neurodegenerative diseases. These taxonomies will represent multi-scale structural and functional understanding of the causal mechanisms of and possible treatments in PD and AD.

Related links:

Latest news of the category:
 - Pharmacoidea is now part of the IM2PACT Consortium
 - Pharmacoidea as an Ambassador for OTP Business
 - The winner of this year’s NO-BLE Ideas Award is Dr. Tamás Letoha!

Most read news of the category:
 - London Health Show 2016 (10353)
 - Organising Mechanistic Knowledge about Neurodegenerative Diseases (10192)
 - Role model of the Year: Tamás Letoha, MD (9647)

Tags: Innovative Medicines Initiative | Aetionomy | organising
Back | 
Read: 10191x | Share:      
Food for thought
High quality herbal remedies
for the health conscious costumers.